03:42 AM EDT, 10/20/2026 (MT Newswires) -- Ondine Biomedical (OBI.L) raised 10 million pounds sterling in gross proceeds from a share placing and subscription launched on Monday. The UK-listed life sciences company will issue 100 million new common shares at 0.10 pound apiece, with trading expected to start on Friday, according to a Tuesday release. Ondine Biomedical expects the net proceeds to provide the company a cash runway into early 2028.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.